<DOC>
	<DOCNO>NCT01539213</DOCNO>
	<brief_summary>The propose exploratory study aim understand vivo skin distribution property subcutaneously ( s.c. ) administer AIN457 psoriatic healthy skin use open flow microperfusion ( OFM ) . The data study help understand mode action AIN457 target tissue . It aim establish technique assess vivo distribution AIN457 metabolites human dermal interstitial fluid ( ISF ) explore potential pharmacodynamic effect situ . In addition , study evaluate safety local tolerability subcutaneously administer AIN457 explore dermal interstitial fluid skin level potential disease relevant biomarkers . The study divide two part - Part I 8 healthy volunteer ( HV ) validate method complete Part II 8 psoriasis patient start base outcome Part I .</brief_summary>
	<brief_title>Distribution Secukinumab ( AIN457 ) Into Dermal Interstitial Fluid After Single Subcutaneous Administration 300 mg</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>For Part I : Healthy male female subject 18 65 year age inclusive ; For Part II : Chronic plaquetype psoriasis ( without arthritis ) diagnose least 6 month enrollment include least one plaque accessible OFM least moderate severity ; Key exclusion criterion Part I Part II : Women childbearing potential unwilling use effective contraception ; History ongoing , chronic recurrent infectious disease , evidence tuberculosis infection define positive TBtest screening ; For Part I : Use prescription drug , herbal supplement , within 4 week prior initial dose For Part II : Ongoing use concomitant psoriasis treatment . Washout period adhere . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>interstitial fluid</keyword>
	<keyword>open flow microperfusion</keyword>
	<keyword>IL-17</keyword>
	<keyword>inflammatory skin disease</keyword>
	<keyword>scaly patch</keyword>
	<keyword>Healthy volunteer psoriasis patient</keyword>
</DOC>